With the proper dosage and precise protocols, hyperbaric oxygen therapy has the ability to heal wounds and infections as well as enhance the activity of the immune system. Learn more about our Hyperbaric Medicine Center and the treatments available from our board-certified specialists.
Artificial intelligence and deep machine learning are being used in a variety of ways to enhance medical research and potentially improve patient care at UT Southwestern.
A novel treatment may reverse resistance to both endocrine therapy and radiation therapy in breast cancer patients. Learn more from UT Southwestern radiation oncologists.
A new radiation therapy approach offers curative potential for gynecologic tumors. Learn about adaptive radiation therapy (ART) and two clinical trials at UT Southwestern to help women with cancer.
David Sher, M.D. explains how a new clinical trial for head and neck cancer patients will study daily adaptive radiotherapy using tumor targeting driven by an AI-driven algorithm developed by UT Southwestern.
UT Southwestern is the only center in North Texas offering cardiac radioablation, a novel therapy that uses focused stereotactic radiation to assist in cardiac ablation for high-risk patients.
James Daniels, M.D. /
Richard Wu, M.D. /
Robert Timmerman, M.D.
Men with localized, low- and intermediate-risk prostate cancer are seeking TULSA: an outpatient, alternative to surgery or active surveillance: no incisions, surgery, or radiation required. Learn more.
Successful outcomes in Gamma Knife radiosurgery require a team approach – and a lot of quality checks. UT Southwestern discusses the process in this week's MedBlog.
U.S #lungcancer rates have declined for decades, except in one group: Young adults who never smoked. UT Southwestern discusses what we know about the risks, as well as ongoing research to reveal more answers.
With brachytherapy, tiny implements deliver radiation directly to a tumor. And the list of cancers for which it is effective is expanding. Learn more about how UT Southwestern is leading the way in brachytherapy in Texas.
Stereotactic ablative therapy (SABR) has proven effective in treating many types of primary tumors. Robert Timmerman, M.D., discusses how SABR might improve survival rates for patients with metastatic cancer.
Radiation therapy for cancer raises plenty of questions – some of which you might feel nervous asking. Nina Sanford, M.D, tackles five common questions patients might be afraid to bring up with their doctors. Read more.
Cancer death rates have dropped nearly 30% since 1991, and more that 2% between 2016 and 2017 alone – the biggest one-year drop on record. The driver has been precision medicine, an approach that focuses on personalization and collaboration. Learn more now.
